Consistent with this result, a recent study [28] examining the prevalence of BRCA1/2 germline mutations in 21,401 families with breast and ovarian cancer history has reported a prevalence of 24.0 % (95 % CI 23.4–24.6 %) [28]. This evidence concerns the gene BRCA1 and ovarian cancer.